Close Menu

NEW YORK – Irish molecular diagnostics firm HiberGene Diagnostics said on Wednesday that it received the CE mark for its new rapid molecular test for SARS-CoV-2.

The test is now available in Ireland and internationally.

It is used with the firm's portable HG Swift instrument to test four samples simultaneously and leverages HiberGene's proprietary molecular reagent format to detect the virus in nose and throat swabs. The company added that the assay employs an easy-to-use freeze-dried reagent format. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nearly 30,000 COVID-19 tests the UK sent to the US came back as void, according to the Telegraph.

Black principal investigators receive less favorable application scores when seeking US National Institutes of Health grants, the Chronicle of Higher Education reports.

New Scientist reports that both RNA and DNA may have been involved in the emergence of life on Earth.

In Nature this week: new Sperm-seq method enables crossover analysis, tumor-informed detection approach for minimal residual disease, and more.

Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.